|
Redwood City, CA – October 9, 2007 –Ingenuity Systems, the leading provider of information
solutions to help life science researchers generate insights
from biological and chemical information, today introduced
IPA-Metabolomics™, a complete solution within IPA to help researchers understand metabolomics
data in the context of dynamic signaling and metabolic
pathways.
"With metabolomics research, we have robust approaches
for generating data, but it has been challenging to extrapolate
biological meaning from that data," stated Larry
Denner, Ph.D., Director, McCoy Diabetes Mass Spectrometry
Laboratory and Professor of Medicine at University of
Texas Medical Branch. "IPA-Metabolomics provides
new analytical tools to understand complex physiological
processes. By enabling the integration of diverse
metabolomics and proteomic data, we can now identify emergent
principles for generating novel testable hypotheses in
our continuing refinement of predictive models of normal
and pathological processes."
"I completely concur with Dr. Denner," says
Bruce Luxon, Ph.D., Professor and Director of UTMB's Bioinformatics
Program and the Metabolomics Laboratory. "We
view the addition of the IPA-Metabolomics module as a
major step forward in our quest to bring together data
from genomics, proteomics, and metabolomics into a cohesive,
coherent picture of the biological context that is embedded
in our 'omics' data. We are very enthusiastic about this
enhancement to the IPA platform."
IPA is a software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA is deployed in all major pharmaceutical companies and in hundreds of biotechnology companies and academic institutions globally. It supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, identification of biomarkers, predictive toxicology, and pharmacogenomics.
About Ingenuity Systems®
Ingenuity enables researchers to model, analyze, and understand
complex biological and chemical systems foundational to
human health and disease. The Ingenuity products include
pathways analysis software and knowledge bases for life
scientists and bioinformaticians, and enterprise knowledge
management infrastructure, content and services for leading
pharmaceutical and biotech companies. Ingenuity was founded
in 1998 and is headquartered in Redwood City, California
with offices in Germany, Switzerland, France, the United
Kingdom, and Japan. www.ingenuity.com.
Contact:
Heidi Bullock
Director, Marketing
Ingenuity Systems
650.381.5150
» View as PDF  |
